Epigenomics

joint with Chromatin Dynamics

Organizer(s): Steven E. Jacobsen and Steven Henikoff

Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc., Novartis Institutes for BioMedical Research and Takeda Pharmaceutical Company Limited

For important information on the coronavirus, please click here

Summary of Meeting:

Core processes of epigenetic inheritance include DNA methylation, histone modification, nucleosome remodeling, nuclear dynamics and chromatin interaction with non-coding RNAs. Although these processes are beginning to be understood at a mechanistic level, less is known of their dynamic nature within genomes. This meeting will highlight recent advances in the application of genomics techniques to the study of epigenetics. Research in a variety of model systems will be presented, which will highlight the conservation and divergence of patterns in different eukaryotic kingdoms. Session topics emphasize integration between epigenomic patterning and developmental regulation, as well as cross-talk between different epigenetic processes. This meeting will also highlight cutting-edge, high-throughput technology being developed and applied to understand epigenomes. Opportunities for interdisciplinary interactions will be significantly enhanced by the concurrent meeting on Chromatin Dynamics, which will share a keynote address and two plenary sessions with this meeting.

Scholarship Deadline: September 20 2011

Discounted Abstract Deadline: September 20 2011

Abstract Deadline: October 20 2011

Discounted Registration Deadline: November 17 2011

Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:

We gratefully acknowledge additional support for this conference from:

We gratefully acknowledge the generous grant for this conference provided by:

National Human Genome Research Institute (NHGRI)
Grant No. 1R13HG006396-01
The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations

Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations